Cannabis Bioscience International Holdings, Inc. (CBIH) Payables (2023 - 2026)
Cannabis Bioscience International Holdings (CBIH) posted Payables of $190467.0 for Q1 2026, down 29.67% sequentially from $270837.0 in Q4 2025, and down 31.78% YoY from $279205.0 in Q1 2025.
Cannabis Bioscience International Holdings, Inc. (CBIH) Payables (2023 - 2026) Analysis & Trends
Cannabis Bioscience International Holdings has reported Payables for 4 years, with the latest figure at $190467.0 in Q1 2026.
- Quarterly Payables fell 31.78% year-over-year to $190467.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $190467.0 (down 31.78% YoY) and the FY2025 annual result came in at $109525.0, down 33.96% from the prior year.
- Payables slipped to $190467.0 in Q1 2026 per CBIH's latest filing, from $270837.0 in the prior quarter.
- Over five years, Payables peaked at $364788.0 in Q4 2023 and troughed at $107660.0 in Q3 2025.
- A 4-year average of $228339.7 and a median of $248931.0 in 2024 frame the typical range for Payables.
- The widest YoY moves for Payables: up 6.16% in 2025, down 56.75% in 2025.
- Over 4 years, Payables stood at $364788.0 in 2023, then fell by 23.59% to $278748.0 in 2024, then fell by 2.84% to $270837.0 in 2025, then declined by 29.67% to $190467.0 in 2026.
- According to Business Quant data, Payables over the past three periods registered $190467.0, $270837.0, and $107660.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 190,467.00 |
| Nov 30, 2025 | 270,837.00 |
| Aug 31, 2025 | 107,660.00 |
| May 31, 2025 | 109,525.00 |
| Feb 28, 2025 | 279,205.00 |
| Nov 30, 2024 | 278,748.00 |
| Aug 31, 2024 | 248,931.00 |
| May 31, 2024 | 165,858.00 |
| Feb 29, 2024 | 263,012.00 |
| Nov 30, 2023 | 364,788.00 |
| May 31, 2023 | 232,706.00 |